Key Takeaways
- Domestic core business delivered 11% growth with 7% volume growth, driven by broad-based brand performance even as mass urban demand stayed subdued.
- Kesh King and The Man Company remain the two active turnarounds: a BCG-designed strategy for Kesh King rolls out in Q2, while new CEO Zairus Master has been mandated to restore growth at TMC this year itself.
- Summer portfolio faces a Q1 air pocket: steep Q4 primary fill met soft consumer offtake in April, especially in talc, as unseasonal rains hit southern and western markets.
- International business rebounded to 6% growth after a Q3 decline, with SAARC, Southeast Asia and CIS offsetting continued stress in Bangladesh, the Middle East and parts of Africa.
- What to watch next quarter: whether the Kesh King strategy rollout and Smart and Handsome relaunch momentum convert into sustained secondary growth, and whether summer products recover in the final weeks of the season.
Domestic Core Business: The Growth Engine
- Broad-based volume growth: Core domestic business grew 11% with volume growth of around 7%, achieved across brands and categories, reflecting a well-rounded portfolio performance.
- Rural leads, mass urban lags: Consumption demand trends remained similar to the previous quarter, with rural markets continuing to perform well while mass urban demand stayed subdued.
- BoroPlus benefits from extended winter: The BoroPlus range grew 27% as winter extended; when summer underperforms, BoroPlus tends to do slightly better, and April-May trends are already showing this pattern on a small base.
- Healthcare portfolio delivers 13% growth: Led by Zanducare D2C at nearly 50% growth, driven by new product launches, better marketing ROI and more aggressive claims; OTC brands like Nityam and Cough Syrup grew in strong double digits, and the medico business also had good growth.
- 25 new products launched this year, primarily under Zandu Care, with management expecting the innovation rate to stay around 3% for FY26.
Mohan Goenka: "When summer doesn't do so well, BoroPlus does slightly better and same trends is what we are seeing also in the first quarter, BoroPlus is doing, though it's a very, very small base, but April and May BoroPlus is shining better than our some of our summer items."
The Turnaround Brands: Kesh King & The Man Company
- Kesh King strategy ready, execution begins Q2: BCG has completed the strategy work addressing medium-term strategic issues and tactical challenges including e-commerce pricing, SKU mix and media effectiveness; rollout is planned for Q2.
- The Man Company gets a CEO and a clean slate: Zairus Master, formerly Chief Business Officer at Honasa Consumer, has joined as CEO and Director; the original promoters have stepped away completely from day-to-day operations including their office presence.
- Master's mandate is explicit: build a good team, restore a stimulating growth rate this year itself, and chart a long-term path to profitability. Management expects a very significant rebound in the months to come.
- Brillare and TMC both targeting high double-digit growth in FY26, with significant investment planned in brand building and top-of-funnel activities; green shoots are already visible in certain channels and categories in April and May.
- TMC revenue disclosed at ~₹150 cr, Brillare at ~₹50 cr, though management declined to share loss figures for either entity.
Giriraj Bagri: "The promoters have stepped away completely from day-to-day operations, including their presence in the office. So they are gone."
Summer Portfolio: The Q1 Headwind
- Q4 primaries collided with soft Q1 offtake: steep growth in Q4 meant primary billing was done, but consumer offtakes in April were not in line with brand preparations, more pronounced in talc than in oil.
- Weather is the culprit: sporadic rainfall across India, with southern markets, parts of lower Maharashtra and parts of Odisha particularly affected; the pain point is concentrated in April.
- Recovery window is narrow: if some markets rebound in the next four weeks, low single-digit growth is possible for the summer portfolio; mid-single digits should not be a problem for talc, while oil looks robust.
- Higher base adds pressure: the summer portfolio faces a tough comparison, compounding the weather-driven softness.
Mohan Goenka: "This quarter is slightly challenging as far as the summer portfolio is concerned. We saw a steep growth in Q4, so primaries happened. Unfortunately, southern markets and some parts of east and west have not done so well."
Brand Relaunches & New Launches
- Smart and Handsome relaunch has arrested the decline: launched in the second week of January with a full 360-degree plan including brand name change, aggressive marketing across TV, OTT and digital, and a revamped go-to-market strategy; Fair and Handsome was fully phased out with zero returns.
- The brand is now positioned in male grooming, not just cream and face wash: growth of 7% reflects secondary growth as well, and extensive male grooming products are planned for rollout in Q2.
- Emami Pure Glow enters the brightening category: a ₹3,000-4,000 crore market with a monopoly held by Lever; currently in test market stage in select southern markets, positioned on nature and science with clinical results of 2x brighter look plus extra moisturization; Rashi Khanna onboarded as brand face.
- Pain management sees stress in the flagship product: the green Zandu Balm pack, the main product in the 20%-of-revenues pain management portfolio, is showing signs of stress, while Ultra Power and Mentho Plus have consistently grown; one or two new offerings are being launched this year.
- Manpower is now complete with Zairus Master's appointment, and with the Kesh King strategy rollout in Q2, management believes all brand relaunches are done.
Mohan Goenka: "So after a long time we have seen some momentum in Smart and Handsome. You guys know that this band was continuously declining. And post the relaunch, we have arrested the de-growth."
International Business & Macro Outlook
- International returned to growth at 6% after a Q3 decline, supported by strong performance in SAARC, Southeast Asia, CIS and Africa regions.
- Pockets of stress persist: Bangladesh improved in Q4 after trouble in Q3, and GCC is showing growth signs, but one or two African countries remain troubled along with parts of the Middle East.
- Domestic consumption pickup expected to be gradual, supported by easing inflation, recent income tax benefits to individual taxpayers, higher government CAPEX and a more accommodative monetary policy including potential rate cuts.
- Gross margins face no pressure: input costs are benign, and a slight benefit of approximately 0.5 bps is possible if crude prices remain at current levels; pricing growth for FY26 is expected to be in the 2-3% range, similar to recent trends.
- Advertising spend stays aggressive this year, with management continuing to invest behind brands.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Kesh King strategy rollout | BCG-designed strategy deployed in market | Q2 FY26 |
| The Man Company growth restoration | Restore stimulating growth rate | FY26 itself |
| Brillare & TMC growth | High double-digit growth for both businesses | FY26 |
| Smart and Handsome male grooming extension | Extensive new products rolled out | Q2 FY26 |
| Pain management new launches | Two new product offerings launched | FY26 |
| Innovation rate | Approximately 3% of revenue from new products | FY26 |
| Pricing growth | 2-3% price-led growth | FY26 |
| Gross margin benefit | ~0.5 bps benefit if crude stays at current levels | FY26 |
| Summer portfolio Q1 growth | Low single-digit growth if markets rebound in four weeks; mid-single digits for talc | Q1 FY26 |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated revenue | ₹963 cr, +8% YoY |
| Domestic core business growth | 11%, volume growth ~7% |
| Overall domestic business growth | 9%, volume growth ~5% |
| Gross margin | 65.9%, expanded 10 bps YoY |
| EBITDA | ₹219 cr, +4% YoY |
| Profit before tax | ₹194 cr, +14% YoY |
| Profit after tax | ₹162 cr, +9% YoY |
| FY25 consolidated revenue | ₹3,809 cr, +6.5% YoY |
| FY25 EBITDA margin | 26.9%, improved 40 bps YoY |
| FY25 total dividend per share | ₹10, 1000% payout, 49% of adjusted PAT |
| Navratna and Dermicool range growth | 16% |
| BoroPlus range growth | 27% |
| Healthcare range growth | 13% |
| Pain management growth | 1% |
| Smart and Handsome growth | 7% |
| Kesh King growth | Flattish |
| International business growth | 6% |
| Strategic investment portfolio revenue decline | 12% |
| Organized channels share of domestic revenue (FY25) | ~28%, +140 bps YoY |
| Zanducare D2C portfolio growth | ~50% YoY |
| Advertising spend (FY25) | >₹690 cr |
| Innovation rate (FY25) | ~4% of revenue from products launched in last 2–3 years |
| The Man Company revenue (FY25) | ~₹150 cr |
| Brillare revenue (FY25) | ~₹50 cr |
| Pricing growth (Q4) | ~3% |
| Pricing growth outlook (FY26) | ~2–3% |